NM_001013627.3:c.56C>G

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_001013627.3(NHSL2):​c.56C>G​(p.Pro19Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000465 in 1,118,497 control chromosomes in the GnomAD database, including 1 homozygotes. There are 28 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 8/12 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000018 ( 0 hom., 2 hem., cov: 23)
Exomes 𝑓: 0.000050 ( 1 hom. 26 hem. )

Consequence

NHSL2
NM_001013627.3 missense

Scores

2
9

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.0900

Publications

0 publications found
Variant links:
Genes affected
NHSL2 (HGNC:33737): (NHS like 2) Predicted to enable calcium ion binding activity. Predicted to be involved in cell differentiation. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004713744).
BS2
High Hemizygotes in GnomAd4 at 2 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NHSL2NM_001013627.3 linkc.56C>G p.Pro19Arg missense_variant Exon 1 of 8 ENST00000633930.2 NP_001013649.2 Q5HYW2-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NHSL2ENST00000633930.2 linkc.56C>G p.Pro19Arg missense_variant Exon 1 of 8 5 NM_001013627.3 ENSP00000488668.1 Q5HYW2-1
ENSG00000300926ENST00000775127.1 linkn.59-430G>C intron_variant Intron 1 of 2
ENSG00000300926ENST00000775128.1 linkn.236-430G>C intron_variant Intron 1 of 2

Frequencies

GnomAD3 genomes
AF:
0.0000177
AC:
2
AN:
112896
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000709
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000139
AC:
9
AN:
64559
AF XY:
0.000338
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000421
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000497
AC:
50
AN:
1005555
Hom.:
1
Cov.:
30
AF XY:
0.0000813
AC XY:
26
AN XY:
319869
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
21829
American (AMR)
AF:
0.00
AC:
0
AN:
25123
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
17379
East Asian (EAS)
AF:
0.00
AC:
0
AN:
24094
South Asian (SAS)
AF:
0.00100
AC:
46
AN:
45772
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
25120
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3008
European-Non Finnish (NFE)
AF:
0.00000250
AC:
2
AN:
800693
Other (OTH)
AF:
0.0000470
AC:
2
AN:
42537
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000177
AC:
2
AN:
112942
Hom.:
0
Cov.:
23
AF XY:
0.0000569
AC XY:
2
AN XY:
35164
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31268
American (AMR)
AF:
0.00
AC:
0
AN:
10885
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2651
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3508
South Asian (SAS)
AF:
0.000712
AC:
2
AN:
2810
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6218
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
214
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53160
Other (OTH)
AF:
0.00
AC:
0
AN:
1546

Age Distribution

Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000142
Hom.:
1
Bravo
AF:
0.00000756
ExAC
AF:
0.000829
AC:
12

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jun 16, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.56C>G (p.P19R) alteration is located in exon 1 (coding exon 1) of the NHSL2 gene. This alteration results from a C to G substitution at nucleotide position 56, causing the proline (P) at amino acid position 19 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_noAF
Benign
-0.32
CADD
Benign
14
DANN
Uncertain
1.0
DEOGEN2
Benign
0.013
T
FATHMM_MKL
Benign
0.14
N
LIST_S2
Benign
0.41
T
MetaRNN
Benign
0.0047
T
MetaSVM
Benign
-1.1
T
PhyloP100
-0.090
PrimateAI
Uncertain
0.78
T
Sift4G
Benign
0.12
T
Vest4
0.089
MutPred
0.34
Loss of loop (P = 0.0075);
GERP RS
3.2
PromoterAI
-0.020
Neutral
gMVP
0.10

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs779389897; hg19: chrX-71130993; API